Skip to main content

and
  1. No Access

    Article

    A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

    Interleukin-11 (IL-11) decreases cytokine release and increases survival in murine BMT models. In these systems, it reduces gut permeability, partially polarizes T cells to a Th2 phenotype, down-regulates IL-1...

    JH Antin, SJ Lee, D Neuberg, E Alyea, RJ Soiffer, S Sonis in Bone Marrow Transplantation (2002)